ADMA Biologics Inc (ADMA)

Debt-to-capital ratio

Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Long-term debt US$ in thousands 72,337 101,326 131,074 130,847 130,594 142,026 140,312 144,301 142,833 141,366 139,811 138,423 94,866 94,363 93,877 93,413 92,969 97,044 96,574 96,129
Total stockholders’ equity US$ in thousands 349,018 231,890 188,269 153,706 135,206 151,437 146,762 145,655 151,974 100,385 114,401 126,933 141,173 102,780 111,594 112,504 88,249 71,376 76,879 96,336
Debt-to-capital ratio 0.17 0.30 0.41 0.46 0.49 0.48 0.49 0.50 0.48 0.58 0.55 0.52 0.40 0.48 0.46 0.45 0.51 0.58 0.56 0.50

December 31, 2024 calculation

Debt-to-capital ratio = Long-term debt ÷ (Long-term debt + Total stockholders’ equity)
= $72,337K ÷ ($72,337K + $349,018K)
= 0.17

The debt-to-capital ratio of ADMA Biologics Inc has fluctuated over the past several years based on the provided data. The ratio ranged between 0.30 and 0.58 during the period from March 31, 2020, to December 31, 2024. Notably, there was a decreasing trend from December 31, 2024, where the ratio was at its lowest point of 0.17.

A debt-to-capital ratio indicates the proportion of a company's capital that is financed through debt. A lower ratio suggests a lower reliance on debt financing, which can be seen as a positive indicator of financial health and stability. Conversely, a higher ratio may indicate higher financial risk due to increased debt levels in the capital structure.

In the case of ADMA Biologics Inc, the fluctuations in the debt-to-capital ratio over time may reflect changes in the company's debt levels and overall capital structure. Further analysis and comparison with industry benchmarks or historical data could provide more insights into the company's leverage and financial risk profile.